Hero Image

The 4th International Online Conference on Biomedicines

10 - 12 May 2027 (CEST)
Online
Event Announcement
The ECB 2027 Conference is Now OPEN for Abstract Submission and Registration.
- Submit your abstracts HERE
- Instructions for authors are available online HERE.
For any inquiries, please contact us at ecb@mdpi.com.

Welcome from
the chairs

Dear Colleagues,

Building on the success of the 2025 edition, we are pleased to announce the 4th International Online Conference on Biomedicines (ECB 2027). This event will once again bring together leading researchers from around the world to share the latest advances in biomedicine. The conference will take place online from 10 to 12 May 2027, organized by the journal Biomedicines (ISSN: 2227-9059; Impact Factor: 3.9; CiteScore: 6.8), a peer-reviewed open access journal published by MDPI.

The conference aims to provide a global platform for scientists and researchers to exchange ideas, discuss emerging challenges, and present recent research achievements in the field of biomedicine. The program will include, but is not limited to, the following topics:
S1. Immune System, Tumor Immunology and Autoimmune Disease
S2. Diabetes, Obesity and Metabolic Diseases
S3. Neuroscience and Neurodegeneration
S4. Cardiology and Cardiovascular Diseases
S5. Cancer Molecular Biology and Precision Medicine
S6. Bone Biology and Regenerative Medicine
S7. Translational Medicine and Nanomedicine
S8. AI in Biomedicines

We warmly invite researchers to submit their abstracts. All submissions will undergo MDPI’s standard peer-review process. After the conference, authors will be invited to submit a full proceeding paper (4–8 pages in length), which will be published in Medical Sciences Forum (ISSN 2673-9992) free of charge. In addition, participants are encouraged to submit a full manuscript to the conference’s Special Issue in Biomedicines, with a 20% discount on the article processing charge (APC).

To acknowledge the support of the conference's esteemed authors and to recognize their outstanding scientific accomplishments, we are pleased to announce that the conference will provide six awards, including Best Oral Presentation Awards and Best Poster Awards. The winners will each receive a certificate and 200 CHF.

We look forward to your contribution in this exciting event.

Best regards,

Conference Chairs
Prof. Dr. Felipe Fregni
Prof. Dr. Georgia Levidou
Assoc. Prof. Dr. Allan Stensballe
Dr. Timo Gaber

Follow the conference organizer on Social Media


Flyers


Meet Our Chairs

Explore more chairs
Prof. Dr. Felipe Fregni

Physical Medicine and Rehabilitation, Harvard Medical School, USA;Prof. Dr. Fregni is a Professor of epidemiology at Harvard T.H. Chan School of Public Health and PM&R at Harvard Medical School. He leads a large clinical research laboratory (Spaulding Neuromodulation Center) funded by major NIH grants and is currently investigating techniques to guide and measure neuroplasticity in brain injury. He has been at the forefront of advancing neurorehabilitation science to treat conditions such as stroke, Parkinson’s disease, and chronic pain. In recognition of his outstanding contributions, he has been awarded the highest honor bestowed by the United States government to outstanding scientists and engineers in the U.S.: the Presidential Early Career Award for Scientists and Engineers (PECASE).

Prof. Dr. Georgia Levidou

Department of Pathology, Paracelsus Medical University, Nuremberg, Germany;Prof. Dr. Georgia Levidou is a consultant Pathologist at the Department of Pathology, Paracelsus medical university in Nuremberg, Germany. She received her medical degree (MD), PhD and MSc in Biostatistics at the University of Athens, Greece. She has a twenty years’ experience on pathology and research acquired in leading research centers and is an author of more than 87 peer-reviewed articles. Her research interests span both cancer diagnostics, cellular and molecular pathology as well as tumor prognostic and therapeutic biomarkers. Prof. Levidou has a special interest in hematopathology and is currently working especially on the field of thymic epithelial tumors.

Dr. Allan Stensballe

Assoc. Prof. Dr. Allan Stensballe is a prominent figure in the fields of proteomics, systems biology, inflammation, biomarker discovery, and omics data analysis. His expertise is deeply rooted in proteomics and the application of proteomics for understanding human disease pathology, especially in the context of precision medicine. He has played a key role in leading precision health research initiatives, fostering technology-driven innovation and strengthening collaboration between academia and industry to address important challenges in global health and wellness.

Dr. Timo Gaber

Department of Medicine, Division of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin, Germany;Dr. Timo Gaber is specializing in inflammatory and autoimmune diseases, with a focus on immunometabolism, cellular signaling, and the molecular mechanisms underlying chronic inflammation. His work explores how metabolic processes influence immune cell function, contributing to the development of targeted therapeutic strategies in rheumatology and clinical immunology.

Important Dates

15 Jan

2027 (23:59 AoE)

15 Mar

2027 (23:59 AoE)

5 May

2027 (23:59 AoE)

Meet Our Speakers

Explore more speakers
Prof. Dr. Federica  Laudisi

Department of Systems Medicine; University of Rome “Tor Vergata”, Rome, Italy;Dr. Federica Laudisi graduated with a degree in cellular and molecular biology at the University of Rome Tor Vergata in 2007. She then earned a PhD in immunological sciences at the Sapienza University of Rome in 2011. After completing my doctoral studies, She moved to Singapore to work as a postdoctoral researcher for 3 years at the Singapore Immunology Network (SIgN), and later relocated to Berlin, Germany, where she conducted research at Charité Universitätsmedizin. In 2015, she returned to Italy to continue my research activities at the Gastroenterology Laboratory at the University of Rome Tor Vergata.

Prof. Dr. Jiang Jiang Qin

Hangzhou Institute of Medicine, Chinese Academy of Sciences: Hangzhou, Zhejiang, China;Dr. Jiang-Jiang Qin is a Professor and Principal Investigator at the Hangzhou Institute of Medicine, Chinese Academy of Sciences, and Deputy Director of the Center for Innovative Drug Research. His laboratory focuses on discovering cancer biomarkers and drug targets, elucidating mechanisms of cancer progression and drug resistance, and developing novel anticancer agents, particularly for gastric and pancreatic cancer.

Prof. Dr. Ciro  Isidoro

Department of Health Sciences, Università del Piemonte Orientale “Amedeo Avogadro”, Novara, Italy;

Dr. Hui-Qi  Qu

Center for Applied Genomics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA;Hui-Qi Qu, MB, PhD, is a Principal Scientist at the Center for Applied Genomics at Children’s Hospital of Philadelphia. His research focuses on human genetics, single-cell transcriptomics, multi-omics, and precision medicine. Prior to joining CHOP, he contributed to the discovery and functional characterization of type 1 diabetes genetics and served as an Assistant Professor at UTHealth, where he investigated genetic predisposition to insulin resistance. He has served as the Associate Editor of the Journal of Medical Genetics since 2009.

Prof. Dr. Ronald Chi Chiu Wang

Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, China;Dr. Ronald Wang is currently a Professor and Deputy Director of Prenatal Genetic Diagnosis Centre of Department of Obstetrics & Gynaecology at The Chinese University of Hong Kong. Dr. Wang joined the department after his MBBS degree with honours in 1994, and he received his first PhD in Surgical Sciences from the Chinese University of Hong Kong in 1998 and his second PhD in Genetics from Japan National Institute of Genetics in 2011. Dr. Wang has major research focus in studying reproduction and development. With wide range of experience in clinical and medical research and teaching, Dr. Wang was appointed to the editorial boards and review panels of many important research funding agents and journals. Dr. Wang has worked on many research projects received a total of over HK$116 million research grants and owned 22 patents. He has published over 370 ISI articles on many acclaimed journals.

Sponsors and Partners

Media partner


Paracelsus Medical University, Klinikum Nuremberg, GermanyMoleculesInternational Journal of Molecular SciencesAcademic Conference Cloud
Conference Secretariat

Cheah Min Cui
Coco Hou
Eastern Zhuang
Liane Zhong

For inquiries regarding submissions and sponsorship opportunities, please feel free to contact us.
Email: ecb@mdpi.com


Powered by Sciforum
Disclaimer
Terms and ConditionsPrivacy PolicyAccessibility